Rankings
▼
Calendar
EWTX Q1 2024 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$35M
Net Income
-$29M
EPS (Diluted)
$-0.33
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$554M
Total Liabilities
$19M
Stockholders' Equity
$535M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$35M
-$26M
-35.2%
Net Income
-$29M
-$23M
-24.9%
← FY 2024
All Quarters
Q2 2024 →